ChronWell provides value-based care developing digital health programs for a wide range of conditions. The company’s other products include a Therapeutic Weight Loss offering that combines diet, exercise, coaching, and remote monitoring, as well as a Digital Care Management offering for chronic gastrointestinal conditions such as irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and chronic constipation.
In December 2021, Chronwell raised USD 6 million in funding to expand the operations of its non-alcoholic fatty liver disease treatment program, LIVErHEALTHY, launched in April 2020 as well as to expand its team.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.